首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >'The Therapy of Elimination First' for Early Acute Mastitis: A Systematic Review and Meta-Analysis
【24h】

'The Therapy of Elimination First' for Early Acute Mastitis: A Systematic Review and Meta-Analysis

机译:早期急性乳腺炎的“消除局部的治疗”:系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the effectiveness of "the therapy of elimination first" in early acute mastitis, using four databases (CNKI, Wanfang, Embase, and PubMed). The study incorporated 2508 patients from 16 randomized controlled trials (RCTs). Included trials used Chinese oral medicine and applied the principle of "Eliminating Therapy" for the early treatment of acute mastitis, with simple antibiotic treatment as a control group. Meta-analysis showed significant differences between the overall effectiveness of oral Chinese medicine using Eliminating Therapy (OCM-ET) and western medicine using antibiotics (WM-A) (odds ratio [OR] = 4.43, 95% confidence interval [CI] = 3.21-6.12, Z = 9.04, and P < 0.00001). Analysis of subgroups based on the use of classic or self-made preparations of the medicines showed smaller statistical heterogeneity among the different subgroups (P > 0.05, I2 <= 50%). The OCM-ET group showed significantly shorter pain relief times [mean difference (MD) = -3.08, 95% CI = (-5.90, -0.26), and P = 0.03] and cure times [MD = -6.27, 95% CI = (-9.68, -2.85), and P = 0.0003] than did the WM-A group. Our findings suggest that OCM-ET can shorten the duration of pain and improve cure time in early acutemastitis patients, with fewer adverse reactions. However, RCTs of higher quality with larger sample sizes are required to confirm these findings.
机译:我们使用四个数据库(CNKI,WANFANG,EMBUSE和PUBMED)评估了早期急性乳腺炎中“消除的疗法”的有效性。该研究纳入了来自16例随机对照试验(RCT)的2508名患者。包括试验使用中国口腔医学,并应用“消除治疗”的原则,以便早期治疗急性乳腺炎,具有简单的抗生素治疗作为对照组。使用抗生素(WM-A)使用消除治疗(OCM-ET)和西药(OCM-A)(ocds比率[或] = 4.43,95%置信区间[ci] = 3.21 -6.12,Z = 9.04和P <0.00001)。基于使用经典或自制制剂的药物的亚组分析显示不同亚组(P> 0.05,I2 <= 50%)的统计异质性较小。 OCM-ET组显着较短的疼痛缓解时间[平均差异(MD)= -3.08,95%CI =(-5.90,0.0.26)和P = 0.03]和固化时间[MD = -6.27,95%CI =(-9.68,-2.85)和p = 0.0003]除了WM-A组。我们的研究结果表明,OCM-ET可以缩短疼痛的持续时间,提高治疗时间在早期的Acutembastitis患者中,具有较少的不良反应。然而,需要具有更大样本尺寸的更高质量的RCT来确认这些发现。

著录项

  • 来源
  • 作者单位

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

    Shanghai Acad Tradit Chinese Med Inst Dermatol Shanghai 201203 Peoples R China;

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

    Shanghai Univ Tradit Chinese Med Yueyang Hosp Integrated Tradit Chinese &

    Western Dept Dermatol;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号